|
Cure Pharmaceutical (CURR) CEO Robert Davidson and CFO Michael Redard at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Robert and Michael to moderate a Q&A session. NobleCon 17 Complete Rebroadcast
|